US FDA panel weighs makeup of next COVID vaccine
Advisers to the US Food and Drug Administration were meeting on Thursday to discuss and vote on whether to recommend targeting one of the currently dominant XBB coronavirus variants in updated COVID-19 shots being developed for a fall vaccination campaign. FDA staff reviewers in documents released this week said available evidence suggests this year’s shots […]
Continue Reading